Earnings Data
Report Date
Aug 06, 2026After Close (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
-0.25Last Year’s EPS
-0.46Same Quarter Last Year
Based on 0 Analysts Ratings
DE:2AB Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
DE:2AB Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Apr 30, 2026 | €0.50 | €0.48 | -2.42% |
Mar 13, 2026 | €0.49 | €0.49 | +1.23% |
Nov 07, 2025 | €0.93 | €0.98 | +6.49% |
Aug 07, 2025 | €1.14 | €1.07 | -6.14% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Barinthus Biotherapeutics (DE:2AB) report earnings?
Barinthus Biotherapeutics (DE:2AB) is schdueled to report earning on Aug 06, 2026, After Close (Confirmed).
What is Barinthus Biotherapeutics (DE:2AB) earnings time?
Barinthus Biotherapeutics (DE:2AB) earnings time is at Aug 06, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Barinthus Biotherapeutics stock?
The P/E ratio of Barinthus Biotherapeutics is N/A.
What is DE:2AB EPS forecast?
DE:2AB EPS forecast for the fiscal quarter 2026 (Q2) is -0.25.